Zoltan Szallasi

26PUBLICATIONS
219CO-AUTHORS
Molecular targetsChemical and thermal processes in energy and combustionPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Feb 13, 2026
A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun

|Jan 16, 2026
Long-term exposure to the ethanol-derived metabolite acetaldehyde elevates structural genomic alterations but not base substitutions.

Rita Lózsa, Bernadett Szikriszt, Eszter Németh

|Mar 04, 2025
Impact of DNA repair deficiency on sensitivity to antibody-drug conjugate (ADC) payloads in bladder cancer.

Surish P Shanmugam, Yuzhen Zhou, Isabella Stelter

|Jan 25, 2025
Histopathology and proteomics are synergistic for high-grade serous ovarian cancer platinum response prediction.

Oz Kilim, Alex Olar, András Biricz

|Jan 09, 2025
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.

Dhruva Biswas, Yun-Hsin Liu, Javier Herrero

|Sep 18, 2024
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.

Miklos Diossy, Viktoria Tisza, Hua Li

Pageof 5

Frequent Collaborators

11 joint publications

Zsofia Sztupinszki

7 joint publications

Judit Börcsök

6 joint publications

Miklos Diossy

6 joint publications

Istvan Csabai